Genetics of Cardiovascular and Neuromuscular Disease
We are studying the genetics of human cardiovascular and neuromuscular disease. There are many different genetic regions that have been associated with the development of cardiomyopathy. An equal number of genetic regions have been associated with muscular dystrophy and there is overlap because some of the identical genes, when mutated, produce both cardiomyopathy and muscular dystrophy. We are working to identify genes and gene mutations associated with cardiomyopathy, arrhythmias and muscular dystrophy. We propose to screen these samples for mutations in genes known to be involved in these disorders.
Conditions:
🦠 Cardiomyopathy 🦠 Arrhythmia 🦠 Muscular Dystrophy
🗓️ Study Start (Actual) September 1996
🗓️ Primary Completion (Estimated) January 2026
✅ Study Completion (Estimated) January 2026
👥 Enrollment (Estimated) 2000
🔬 Study Type OBSERVATIONAL
📊 Phase N/A
Locations:
📍 Chicago, Illinois, United States

📋 Eligibility Criteria

Description

    Inclusion Criteria:

    • * Patients of all ages will be considered for the study. In particular, families with more than one affected relative will be sought.

    Exclusion Criteria:

    • * Subjects without a suspected inherited cardiovascular or neuromuscular disorder will be excluded from this study.
Ages Eligible for Study: N/A to N/A (CHILD, ADULT, OLDER_ADULT)
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers: No

🗓️ Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

  • First Submitted 29 August 2005
  • First Submitted that Met QC Criteria 29 August 2005
  • First Posted 30 August 2005

Study Record Updates

  • Last Update Submitted that Met QC Criteria 25 July 2024
  • Last Update Posted 26 July 2024
  • Last Verified July 2024